ResearcherKyoto UniversityNo recent work listed
Tosiya Shun Sato
Matched on ORCID iD 0000-0001-9830-013X; OpenAlex author ID A5056206082. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper
Papers 4
- Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data From 2 Clinical Trials. Co-author DOI 10.1097/mpa.0000000000001879↗
- A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. Co-author DOI 10.1007/s00280-018-3577-9↗
- A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2012.03.059↗
- Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer. Last author DOI 10.1093/jjco/hyr090↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Junji Furuse · 4 shared papers, 2011–2021 · strength 0.24
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. DOI 10.1007/s00280-018-3577-9↗
- Paper A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2012.03.059↗
- Takuji Okusaka · 4 shared papers, 2011–2021 · strength 0.24
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. DOI 10.1007/s00280-018-3577-9↗
- Paper A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2012.03.059↗
- Hiroshi Ishii · 3 shared papers, 2013–2021 · strength 0.21
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. DOI 10.1007/s00280-018-3577-9↗
- Paper A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2012.03.059↗
- Masafumi Ikeda · 3 shared papers, 2013–2021 · strength 0.21
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. DOI 10.1007/s00280-018-3577-9↗
- Paper A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2012.03.059↗
- Nobumasa Mizuno · 2 shared papers, 2018–2021 · strength 0.18
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. DOI 10.1007/s00280-018-3577-9↗
- Naohiro Sata · 2 shared papers, 2018–2021 · strength 0.18
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. DOI 10.1007/s00280-018-3577-9↗
- Makoto Ueno · 2 shared papers, 2018–2021 · strength 0.18
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer. DOI 10.1007/s00280-018-3577-9↗
- Tatsuya Ioka · 2 shared papers, 2013–2021 · strength 0.14
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2012.03.059↗
- Shoji Nakamori · 2 shared papers, 2011–2021 · strength 0.13
- Paper Impact of Renal Function on S-1 + Radiotherapy for Locally Advanced Pancreatic Cancer: An Integrated Analysis of Data F… DOI 10.1097/mpa.0000000000001879↗
- Paper Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreat… DOI 10.1093/jjco/hyr090↗
- Akira Fukutomi · 1 shared paper, 2021 · strength 0.11
- Satoshi Kobayashi · 1 shared paper, 2021 · strength 0.11
- Kunihiro Tsuji · 1 shared paper, 2018 · strength 0.07
- Masato Ozaka · 1 shared paper, 2018 · strength 0.07
- Kenji Yamao · 2 shared papers, 2011–2013 · strength 0.06
- Paper A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer. DOI 10.1016/j.ijrobp.2012.03.059↗
- Paper Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreat… DOI 10.1093/jjco/hyr090↗
- Shinichi Ohkawa · 1 shared paper, 2011 · strength 0.02
- Narikazu Boku · 1 shared paper, 2011 · strength 0.02
- Osamu Yokosuka · 1 shared paper, 2011 · strength 0.02
- Akihiro Funakoshi · 1 shared paper, 2011 · strength 0.02
- Fuminori Moriyasu · 1 shared paper, 2011 · strength 0.02
- H. Ueno · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.